Paris, France

Fabian Docagne

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fabian Docagne: Innovator in Neurological Treatments

Introduction

Fabian Docagne is a notable inventor based in Paris, France. He has made significant contributions to the field of medical science, particularly in the treatment of neurological and neurodegenerative disorders. His innovative work has the potential to impact many lives.

Latest Patents

Fabian Docagne holds a patent for an antibody that is useful in treating neurological or neurodegenerative disorders. The patent, titled "Antibody useful in neurological or neurodegenerative disorders," describes an anti-NMDA antibody or its fragments and derivatives. This invention is effective in inhibiting the harmful effects of tissue-type plasminogen activator (t-PA) mediated by N-methyl-D-aspartate (NMDA) receptors. It has promising medical applications, especially for conditions like multiple sclerosis. He has 1 patent to his name.

Career Highlights

Throughout his career, Fabian has worked with reputable organizations, including Paion Deutschland GmbH and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Fabian has collaborated with esteemed colleagues such as Richard Macrez and Denis Vivien. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Fabian Docagne is a distinguished inventor whose work in the field of neurological treatments showcases his dedication to improving medical science. His innovative patent has the potential to change the landscape of treatment for neurodegenerative disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…